Financials
- Market Capitalization 215.58 M
- Employee 95
- Founded N/A
- CEO Daniel Vitt
- Website www.imux.com
- Headquarter Delaware, United States
- FIGI BBG001M75SX4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.34
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3537 | NERV Minerva Neurosciences, Inc - Common Stock | 4.56 USD | -5.79% | -5.98% | +15.44% | +94.04% | 217.73 M USD | ||
| 3542 | TARA Protara Therapeutics, Inc. - Common Stock | 3.84 USD | +0.52% | -0.52% | -2.54% | +22.68% | 226.93 M USD | ||
| 3572 | KROS Keros Therapeutics, Inc. - common stock | 10.82 USD | -1.90% | -1.73% | +6.50% | -28.34% | 214.53 M USD | ||
| 3576 | GLSI Greenwich LifeSciences, Inc. - Common stock | 14.95 USD | -4.59% | -14.38% | +10.74% | +28.88% | 219.44 M USD |